Oncology & Cancer
Study uncovers how B cells react to skin cancer
A new study that sheds light on how B cells react to skin cancer cells could pave the way for innovative therapy design.
Jun 8, 2023
0
33
Autoimmune Diseases
Diseases, Conditions, Syndromes
Multiple sclerosis discovery IDs key factor that shapes your risk
University of Virginia School of Medicine scientists have discovered a key determinant of our risk for multiple sclerosis (MS), advancing efforts to prevent and better treat the disease.
Jun 7, 2023
0
20
Diseases, Conditions, Syndromes
Pumping the brakes on autoimmune disease
Researchers at Sanford Burnham Prebys, collaborating with scientists from Eli Lilly and Company, have revealed the structure and function of a drug called LY3361237, which can reduce the harmful activity of the immune system ...
Jun 5, 2023
0
72
Diseases, Conditions, Syndromes
CDC warns of potentially fatal bacterial illness on US gulf coast
A potentially deadly germ has made its way to the U.S. Gulf Coast, health officials warned this week.
Jun 2, 2023
0
62
Neuroscience
A little-understood sleep disorder affects millions and has clear links to dementia—4 questions answered
A little-known and poorly understood sleep disorder that occurs during the rapid eye movement, or REM, stage of sleep has been garnering attention for its role in foreshadowing neurodegenerative brain diseases such as Parkinson's ...
May 26, 2023
0
10
Medications
New study: Type 2 diabetes drug could treat autoimmune disorders
Swansea University researchers have found that a drug commonly used to treat type 2 diabetes can potentially be used in the treatment of autoimmune disorders.
May 25, 2023
0
15
Diseases, Conditions, Syndromes
Multiple sclerosis: New evidence for the role of Epstein-Barr virus
An estimated 2.8 million people around the world have multiple sclerosis (MS), an autoimmune disease in which the immune system damages the brain and spinal cord.
May 22, 2023
0
6
Medications
Peresolimab found to be efficacious for rheumatoid arthritis
Peresolimab, a humanized immunoglobulin G1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway, is efficacious for patients with rheumatoid arthritis, according ...
May 18, 2023
0
18
Arthritis & Rheumatism
How intravenous immunoglobulin antibodies resolve joint inflammation in rheumatoid arthritis
Immunoglobulin G antibodies (IgB) play an important role as drivers of inflammation in infectious diseases and autoimmune diseases. However, if the same immunoglobulin antibodies from the blood plasma of healthy donors are ...
May 10, 2023
0
6
Immunology
Autoimmune disorders found to affect around 1 in 10 people
A new population-based study of 22 million people shows that autoimmune disorders now affect about 1 in 10 individuals. The work, published in The Lancet, also highlights important socioeconomic, seasonal, and regional differences ...
May 8, 2023
0
132
